Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting ...

Better continence, erectile function, but data on oncologic outcomes still 2 years away ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to ...

TRE-515 has received FDA fast track designation for treating PSMA-positive mCRPC, aiming to accelerate its development and availability. The drug is being tested in combination with Pluvicto, a ...

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the Government-funded National Institute for Health and Care Research (NIHR), the trial ...

Cribriform-positive morphology was associated with a 3.6-fold higher risk for metastasis in patients with prostate cancer, and radiotherapy with neoadjuvant androgen deprivation therapy (ADT) was ...

With Joe Biden’s recent diagnosis of an aggressive form of prostate cancer, the former U.S. president joins a growing group of people newly coping with the disease. Biden, 82, represents one of more ...

Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.